4th – 6th March 2024
The goal of the NDLR Meeting is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia, lymphoma and multiple myeloma to new therapies emerging in the clinic.
As one of the premier international leukaemia Meetings, NDLR 2024 will again bring together early career investigators, senior scientists and clinicians. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, forging new collaborations.
Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR Meeting offers a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field and therefore offers sponsoring organisations unrivalled exposure and recognition.
This Meeting also provides the opportunity for the industry to interact with experts in the field of leukaemia research and clinical haematology (haematologists/oncologists).
For more information, visit the NDLR website.